title: The value of the donor MEGX test in predicting liver allograft recipient outcome.
authors.affiliation: Queensland Liver Transplant Service, Princess Alexandra Hospital, Wooloongabba, Australia.
authors.forename: J M
authors.initials: JM
authors.lastname: Potter
authors.forename: G A
authors.initials: GA
authors.lastname: Balderson
authors.forename: P E
authors.initials: PE
authors.lastname: Hickman
authors.forename: A
authors.initials: A
authors.lastname: Henderson
authors.forename: M
authors.initials: M
authors.lastname: Wright
authors.forename: B
authors.initials: B
authors.lastname: Burrow
authors.forename: S V
authors.initials: SV
authors.lastname: Lynch
authors.forename: T H
authors.initials: TH
authors.lastname: Ong
authors.forename: R W
authors.initials: RW
authors.lastname: Strong
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006084:Graft Rejection / Q000175:diagnosis*; D006801:Humans; D007223:Infant; D008012:Lidocaine / Q000031:analogs & derivatives*; D008111:Liver Function Tests / Q000379:methods*; D016031:Liver Transplantation / Q000502:physiology*; D008875:Middle Aged; D011237:Predictive Value of Tests; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D008012:Lidocaine; C001173:monoethylglycinexylidide